Clinical Trials Directory

Trials / Unknown

UnknownNCT02985294

Peripheral Physiological Measures as Determinants of Pain Risk

DOLORisk: Understanding Risk Factors and Determinants for Neuropathic Pain - Peripheral Physiological Measures as Determinants of Pain Risk

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Neuroscience Technologies SLP, Barcelona · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates peripheral nervous system function using Multiple Excitability Measures (MEM) to obtain "electrophysiological pain phenotypes"

Detailed description

Using MEM for peripheral sensory and motor axons we want to identify a set of excitability measures that: 1. Correlate with parameters of clinical pain and of pain processing in existing pain patients (cross sectional study), with the aim to obtain an objective Pain Biomarker. 2. Predict development of neuropathic pain in susceptible patients (longitudinal study). Neuropathic Pain Predictor for patients: i. Undergoing surgical procedures associated with a relatively high risk of developing neuropathic pain such as thoracotomy and hernia repair ii. Planning to start chemotherapy with potentially neurotoxic agents such as vincristine

Conditions

Interventions

TypeNameDescription
OTHERMultiple Excitability Measures of peripheral nervesThe technique of threshold tracking can be used to obtain several measures of peripheral nerve excitability (Multiple Excitability Measures or MEM), such as refractoriness, supernormality, strength-duration time constant and 'threshold electrotonus' (i.e. the changes in threshold produced by long-lasting depolarizing or hyperpolarizing current pulses). Each of these measurements depends on membrane potential and on other biophysical properties of the axons. Many of these excitability parameters are very constant among different subjects, while other, such as the current/threshold parameters and the super/sub-excitability parameters, appear to be characteristic of an individual

Timeline

Start date
2016-04-01
Primary completion
2019-03-01
Completion
2020-04-01
First posted
2016-12-07
Last updated
2018-08-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02985294. Inclusion in this directory is not an endorsement.